Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 12/20 | 0.55 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.44 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.44 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.44 |
| ▸ | HTR2A | P28223 | 2/20 | 0.35 |
| ▸ | HTR2C | P28335 | 2/20 | 0.35 |
| ▸ | FAP | Q12884 | 1/20 | 0.34 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.34 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.34 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.34 |
| ▸ | MAOA | P21397 | 1/20 | 0.33 |
| ▸ | MAOB | P27338 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL13730064 | 0.98 | DPP4 (0.53) | DPP4SLC6A2SLC6A4SLC6A3HTR2A | |
| Phosphoric Acid SCHEMBL13730179 | 0.89 | DPP4 (0.46) | DPP4SLC6A2SLC6A4SLC6A3FAP | |
| Phosphoric Acid SCHEMBL14128619 | 0.88 | DPP4 (0.45) | DPP4SLC6A2SLC6A4SLC6A3FAP | |
| Trifluoroacetic Acid SCHEMBL3134971 | 0.85 | DPP4 (0.42) | DPP4SLC6A2SLC6A4SLC6A3FAP | |
| Adipic Acid SCHEMBL13729711 | 0.84 | GABRP (0.44) | DPP4FAPDPP8DPP9DPP7 | |
| SCHEMBL15091259 | 0.82 | DPP4 (0.42) | DPP4SLC6A2SLC6A4SLC6A3HTR2A | |
| SCHEMBL7140782 | 0.79 | TYR (0.52) | DPP4SLC6A4HTR2AHTR2CMAOB | |
| SCHEMBL14071704 | 0.78 | DPP4 (0.70) | DPP4HTR2AHTR2C | |
| Hydrochloric Acid SCHEMBL3121618 | 0.77 | DPP4 (0.68) | DPP4HTR2AHTR2C | |
| Gentisic Acid SCHEMBL13729892 | 0.77 | CA1 (0.49) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2681220-A2 | NOVEL SALTS OF DPP-IV INHIBITOR | Cadila Healthcare Limited (IN) | 2014-01-08 | — | — | EP | claimed |
| WO-2012147092-A2 | NOVEL SALTS OF DPP-IV INHIBITOR | CADILA HEALTHCARE LIMITED (IN) | 2012-11-01 | — | — | WO | claimed |
| EP-1973918-A2 | DERIVATIVES OF BETA-AMINO ACID AS DIPEPTIDYL PEPTIDASE-IV INHIBITORS | RANBAXY LABORATORIES, LTD. (IN) | 2008-10-01 | — | — | EP | claimed |
| WO-2007077508-A2 | DERIVATIVES OF BETA-AMINO ACID AS DIPEPTIDYL PEPTIDASE-IV INHIBITORS | RANBAXY LABORATORIES LIMITED (IN) | 2007-07-12 | — | — | WO | claimed |
| EP-4337192-A1 | COMPOSITIONS FOR USE IN THE PREVENTION AND/ OR TREATMENT OF INTELLECTUAL DISABILITY AND NEURODEGENERATIVE DISEASES IN A SUBJECT WITH DOWN SYNDROME | Università degli Studi di Roma "La Sapienza" (IT) | 2024-03-20 | — | — | EP | disclosed |
| WO-2022238779-A1 | COMPOSITIONS FOR USE IN THE PREVENTION AND/ OR TREATMENT OF INTELLECTUAL DISABILITY AND NEURODEGENERATIVE DISEASES IN A SUBJECT WITH DOWN SYNDROME | UNIVERSITA' DEGLI STUDI DI ROMA "LA SAPIENZA" (IT) | 2022-11-17 | — | — | WO | disclosed |
| CN-105073983-B | Immobilization transaminase and preparation and the method for using immobilization transaminase | 默沙东公司 | 2018-09-18 | — | — | CN | disclosed |
| CN-107961377-A | Combination treatment | 勃林格殷格翰国际有限公司 | 2018-04-27 | — | — | CN | disclosed |
| CN-107115530-A | Gene diabetes mellitus type utilizes the treatment of DPP IV inhibitor such as BI 1356 | 勃林格殷格翰国际有限公司 | 2017-09-01 | — | — | CN | disclosed |
| CN-106975074-A | Treating diabetes | 勃林格殷格翰国际有限公司 | 2017-07-25 | — | — | CN | disclosed |
| CN-104788456-A | Novel salts of DDP-IV inhibitor | CADILA HEALTHCARE LTD | 2015-07-22 | — | — | CN | disclosed |
| EP-2800555-A2 | PHARMACEUTICAL COMPOSITIONS OF COMBINATIONS OF DIPEPTIDYL PEPTIDASE-4 INHIBITORS WITH ATORVASTATIN | Merck Sharp & Dohme Corp. (US) | 2014-11-12 | — | — | EP | disclosed |
| EP-2681220-A2 | NOVEL SALTS OF DPP-IV INHIBITOR | Cadila Healthcare Limited (IN) | 2014-01-08 | — | — | EP | disclosed |
| EP-2681220-A2 | NOVEL SALTS OF DPP-IV INHIBITOR | Cadila Healthcare Limited (IN) | 2014-01-08 | — | — | EP | disclosed |
| WO-2013065066-A1 | PROCESSES FOR PREPARING 4-OXO-4-[3-(TRIFLUOROMETHYL)-5,6- DIHYDRO [L,2,41-TRIAZOLO[43-A]PYRAZIN-7(8H)-YL]-L-(2,4,5- TRIFLUOROPHENYL)BUTAN-2-AMINE | CADILA HEALTHCARE LIMITED (IN) | 2013-05-10 | — | — | WO | disclosed |
| WO-2013062902-A2 | PHARMACEUTICAL COMPOSITIONS OF COMBINATIONS OF DIPEPTIDYL PEPTIDASE-4 INHIBITORS WITH ATORVASTATIN | MERCK SHARP & DOHME CORP. (US) | 2013-05-02 | — | — | WO | disclosed |
| WO-2012147092-A3 | NOVEL SALTS OF DPP-IV INHIBITOR | CADILA HEALTHCARE LIMITED (IN) | 2013-03-14 | — | — | WO | disclosed |
| WO-2012147092-A2 | NOVEL SALTS OF DPP-IV INHIBITOR | CADILA HEALTHCARE LIMITED (IN) | 2012-11-01 | — | — | WO | disclosed |
| WO-2012147092-A2 | NOVEL SALTS OF DPP-IV INHIBITOR | CADILA HEALTHCARE LIMITED (IN) | 2012-11-01 | — | — | WO | disclosed |